Can a structured chat with a nurse boost medication adherence in IBD?

NCT ID NCT07652840

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This trial tests whether a nurse-led education program, based on the Health Belief Model, can improve treatment adherence in people with inflammatory bowel disease (Crohn's disease or ulcerative colitis) who are receiving anti-TNF therapy. The program aims to address patients' concerns and barriers to taking their medication as prescribed. The study compares this structured education to the standard education usually given in clinics, measuring adherence and patient-nurse collaboration.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
structured patient education program
What this could lead to
If effective, this education program could help people with inflammatory bowel disease stick to their anti-TNF treatment, potentially improving disease control and quality of life.
What could go wrong
This is a relatively small, early-stage behavioral study. The results may not apply to all IBD patients or settings, and adherence improvements may not translate to long-term health benefits.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADHERENCE, PATIENT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Crohn disease Health Behavior inflammatory bowel disease Medication Adherence Patient Compliance Patient Participation Treatment Adherence and Compliance ulcerative colitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Izmir Ekonomi University Medical Point Hospital

    Izmir, Turkey (Türkiye)

  • İzmir Atatürk Training and Research Hospital

    Izmir, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.